8223.Hk
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company's capital structure is characterized by a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.54, suggesting the company has sufficient short-term assets to cover its short-term liabilities. The company's market price is 0.305, and its market capitalization is 157,380,000, with a price-to-book ratio of 0.53, indicating that the market value is trading below the book value.
Profitability metrics show a return on equity of -0.0363 and a return on assets of -0.0132, both of which are negative, indicating that the company is not generating returns for its shareholders or assets. The company's net income is negative at -10,700,000, and its operating income is 6,623,000, suggesting that while the company is generating some operating profits, it is not sufficient to cover all expenses.
The company's revenue is concentrated in a single segment, as disclosed in its financials, with no specific geographic breakdown provided. This lack of diversification may pose a risk if the company's primary market experiences a downturn.
The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. The company's revenue history shows a total revenue of 513,762,000, but without comparative data, it is difficult to assess the growth rate.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face challenges in maintaining its liquidity position. The dilution potential is low, and no specific adjustments have been applied to the valuation metrics.
Recent events and filings have not been disclosed in the provided data, so there is no information available on any recent developments that may impact the company's operations or financial position.
- The company is operating in the healthcare services and equipment industry with a focus on medical equipment, supplies, and distribution.
- The company's financial performance is weak, with negative returns on equity and assets, and a net loss.
- The company's liquidity position is medium, with a current ratio of 1.54, but it has a negative net cash position after subtracting total debt.
- The company's growth trajectory is unclear due to the lack of specific numeric deltas for the current and next fiscal years.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
- margin_outlook_rationale: The company's margin outlook is negative due to the current net loss and low profitability metrics.
- rd_outlook_rationale: There is no specific information provided on the company's research and development outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 8223.HK Market data — financials · 2026-05-27